Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale

Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale

Emergency department (ED) visits for suicidal ideation or behavior have been increasing in all age groups, particularly younger adults. A rapid-acting treatment to reduce suicidal thinking, adapted for ED use, is needed. Previous studies have shown a single dose of ketamine can improve depression an...

Full description

Bibliographic Details
Main Authors: Sumra Sajid, Ryan E. Lawrence, Hanga C. Galfalvy, John G. Keilp, Vivek K. Moitra, J. John Mann, Michael F. Grunebaum
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Affective Disorders Reports
Subjects:
Ketamine
Emergency department
Intramuscular
Suicide
Clinical trial design
Online Access:http://www.sciencedirect.com/science/article/pii/S2666915323002275

Similar Items

Similar Items